Wiley Matthew T. 4
4 · BioXcel Therapeutics, Inc. · Filed Jan 19, 2022
Insider Transaction Report
Form 4
Wiley Matthew T.
Other
Transactions
- Award
Stock Option (Right to Buy)
2022-01-17+85,000→ 85,000 totalExercise: $19.50Exp: 2032-01-16→ Common Stock (85,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of January 17, 2022 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.